[Clinical trial with a new antilipemic agent in chronic cerebrovascular insufficiency].
D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D002784:Cholesterol / Q000097:blood; D003911:Dextrans / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D002546:Ischemic Attack, Transient / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use; D011736:Pyridoxine / Q000627:therapeutic use; D013464:Sulfuric Acids / Q000627:therapeutic use; D013831:Thiamine / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D003911:Dextrans; D009539:Nicotinic Acids; D013464:Sulfuric Acids; D002784:Cholesterol; D011736:Pyridoxine; D013831:Thiamine
Ensayo clínico con un nuevo antilipémico en la insuficiencia vascular cerebral crónica.